COVID-19 RESOURCE CENTER

Our experts are publishing articles and supporting companies that are working with health solutions to help solve the global pandemic.

Published in major journals and media, the following features are tracking the evolving developments of the COVID-19 pandemic.

Novateur Ventures: Overlooked Generic Drug Strategy May Prevent COVID-19’s Cytokine Storm

Two generic anti-inflammatory drugs typically used in asthma treatments are being proposed for use with COVID-19 because of their potential to dampen disease progression and severity.

Featured in

Date

Aug 19, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial

Novateur Ventures: Overlooked Generic Drug Strategy May Prevent COVID-19’s Cytokine Storm

Novateur Study Points Toward Potential COVID-19 Treatment

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases

Date

Aug 17, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial, preclinical, reasearch

Novateur Study Points Toward Potential COVID-19 Treatment

Novateur Ventures Explores New Strategy to Reduce the Hyperinflammatory Response Caused by COVID-19

A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a leading peer-reviewed journal. The strategy co-authored by Ali Ardakani, Founder & Managing Director at Novateur Ventures, and Dr. Colin D. Funk (Queen's University, Kingston) analyzes lipid mediators, known as leukotrienes, as the cause for hyperinflammatory response manifested in severe COVID-19 cases. Patients with severe COVID-19 develop an overwhelming state of inflammation with multi-organ dysfunction and leukotrienes have been overlooked.

Featured in

Date

Aug 06, 2020

COVID-19, SARS-CoV-2, leukotrienes, cytokine storm, coronavirus, inflammatory response, vascular leak, clinical trial

Novateur Ventures Explores New Strategy to Reduce the Hyperinflammatory Response Caused by COVID-19

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

Researchers have learned valuable lessons from COVID-19 antibody testing in the population, including those about the challenges in using the method at an individual level.

Featured in

Date

Jul 26, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada, Health Canada

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

Researchers have learned valuable lessons from COVID-19 antibody testing in the population, including those about the challenges in using the method at an individual level.

Featured in

Date

Jul 26, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada, Health Canada

COVID-19 Antibody Testing Has Yielded Useful Data for Public Health but Cautions for Individual Use

A New Study Evaluated the Accuracy of More Than 60 Coronavirus Antibody Tests. 13 Were a Cut Above the Rest.

Hopes were high when the first coronavirus antibody tests debuted a few months ago. There was talk of issuing immunity passports based on the results. The tests were so coveted in the US that the Food and Drug Administration allowed some to go straight to market.

Featured in

Date

Jul 23, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Emergency Use Authorization, EUA, FDA

A New Study Evaluated the Accuracy of More Than 60 Coronavirus Antibody Tests. 13 Were a Cut Above the Rest.

Antibody Survey Reveals ‘Widespread Vulnerability’ to COVID-19 Across Canada, Expert Says

Fewer than 1 per cent of Canadians have had the virus that causes COVID-19, according to initial findings from the largest serological survey conducted to date across the country. The results, released Thursday, are based on 10,000 anonymized blood donations. They offer the best glimpse so far at the extent of the disease beyond the official count of confirmed cases, which now stands at just more than 112,000. The actual number of cases could be three times that, although sample size and testing uncertainties mean it is not yet possible to make a more precise estimate.

Featured in

Date

Jul 23, 2020

COVID-19, SARS-CoV-2, coronavirus, antibody tests, serological tests, diagnostics, Canada

Antibody Survey Reveals ‘Widespread Vulnerability’ to COVID-19 Across Canada, Expert Says

Quest Wins EUA for Four-Swab Pooling via PCR Diagnostic; Hahn Says ‘Important Step Forward’

The U.S. FDA announced July 18 that it has granted an emergency use authorization (EUA) to Quest Diagnostics Inc. for the company’s real-time, reverse transcriptase polymerase chain reaction test for the SARS-CoV-2 virus in a development that FDA commissioner Stephen Hahn described as “an important step forward.”

Featured in

Date

Jul 20, 2020

COVID-19, SARS-CoV-2, coronavirus, diagnostics, Emergency Use Authorization, EUA, FDA

Quest Wins EUA for Four-Swab Pooling via PCR Diagnostic; Hahn Says ‘Important Step Forward’

New Study Ranks Performance of Currently Available COVID-19 Antibody Tests

Conducted by researchers at NSF International and Novateur Ventures, the peer-reviewed study finds significant variability in the accuracy of available COVID-19 antibody tests

COVID-19, coronavirus, SARS-CoV-2, antibody tests, diagnostics, FDA, EUA, Emergency Use Authorization

New Study Ranks Performance of Currently Available COVID-19 Antibody Tests

Ali Ardakani of Novateur Ventures: How We Plan to Rebuild in the Post COVID Economy

Adaptation is the key to success. Seek opportunities during the COVID-19 times to advance your healthcare innovation. This is something that nature does well, and that we should learn from: rapid development to new information and the integration of that wisdom to respond with collective intelligence in the future.

Date

Jul 06, 2020

COVID-19, business, economy, moving forward, Post-Covid

Ali Ardakani of Novateur Ventures: How We Plan to Rebuild in the Post COVID Economy
Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!